Qube Research & Technologies Ltd

Position in RCKT — Rocket Pharmaceuticals, Inc.

CIK 1729829 LONDON, X0

Position in RCKT

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$2,205,451

+$1,433,346 QoQ

Shares Held

644,869

+193.2% QoQ

Ownership

0.587%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#29

of 180 holders

Holding Since

Mar 2021

13 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Qube Research & Technologies Ltd holds $2,443,042,063 across 169 Biotechnology names. RCKT ranks #100 (0.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ALNY	Alnylam Pharmaceuticals, Inc.	798,715	$240,437,176
2	INSM	INSMED Inc	1,682,334	$179,370,451
3	REGN	Regeneron Pharmaceuticals, Inc.	221,607	$138,180,828
4	ROIV	Roivant Sciences Ltd.	3,454,496	$122,254,613
5	AXSM	Axsome Therapeutics, Inc.	426,336	$104,354,262
6	APGE	Apogee Therapeutics, Inc.	659,678	$87,559,060
7	TVTX	Travere Therapeutics, Inc.	1,443,230	$81,989,896
8	RPRX	Royalty Pharma plc	1,412,112	$79,177,119

13 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$2,205,451	644,869	+193.2%	Shares	Sole	2026-08-14
2025-12-31	$772,105	219,973	-78.3%	Shares	Sole	2026-02-17
2025-09-30	$3,306,807	1,014,358	-34.5%	Shares	Sole	2025-11-14
2025-06-30	$3,793,241	1,548,262	+690.8%	Shares	Sole	2025-08-14
2025-03-31	$1,305,939	195,793	+10.3%	Shares	Sole	2025-05-15
2024-03-31	$4,782,496	177,524	+39.9%	Shares	Sole	2024-05-14
2023-09-30	$2,599,402	126,862	-52.5%	Shares	Sole	2023-11-13
2023-06-30	$5,302,428	266,856	+170.5%	Shares	Sole	2023-08-14
2023-03-31	$1,689,857	98,649	+79.6%	Shares	Sole	2023-05-15
2022-06-30	$755,905	54,935	+75.3%	Shares	Sole	2022-08-15
2022-03-31	$497,131	31,345	+10.7%	Shares	Sole	2022-05-09
2021-12-31	$618,138	28,316	+107.4%	Shares	Sole	2022-02-10
2021-03-31	$605,650	13,650	—	Shares	Sole	2021-05-14
No filing history on record for this holder in this stock.